Bristol-Myers Squibb Company (BMY) Earnings History
Annual and quarterly earnings data from 1989 to 2025
Loading earnings history...
BMY EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BMY Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 67.6% | 26.3% | 14.6% |
| 2024 | 56.8% | 20.0% | -18.5% |
| 2023 | 56.3% | 18.8% | 17.8% |
| 2022 | 57.4% | 20.1% | 13.7% |
| 2021 | 57.7% | 20.6% | 15.1% |
Download Data
Export BMY earnings history in CSV or JSON format
Free sign-in required to download data
Bristol-Myers Squibb Company (BMY) Earnings Overview
As of May 6, 2026, Bristol-Myers Squibb Company (BMY) reported trailing twelve-month net income of $7.28B, reflecting +178.2% year-over-year growth. The company earned $3.56 per diluted share over the past four quarters, with a net profit margin of 14.6%.
Looking at the long-term picture, BMY's historical earnings data spans multiple years. The company achieved its highest annual net income of $10.61B in fiscal 2009.
Bristol-Myers Squibb Company maintains positive profitability with a gross margin of 67.6%, operating margin of 26.3%, and net margin of 14.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including PFE ($7.49B net income, 12.4% margin), MRK ($18.25B net income, 28.1% margin), ABBV ($4.23B net income, 6.9% margin), BMY has outperformed on profitability metrics. Compare BMY vs PFE →
BMY Earnings vs Peers
Earnings metrics vs comparable public companies
BMY Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7.05B | +178.8% | $12.70B | $3.45 | 14.6% | 26.3% |
| 2024 | -$8.95B | -211.5% | $9.66B | $-4.41 | -18.5% | 20.0% |
| 2023 | $8.03B | +26.8% | $8.47B | $3.86 | 17.8% | 18.8% |
| 2022 | $6.33B | -9.5% | $9.27B | $2.95 | 13.7% | 20.1% |
| 2021 | $6.99B | +177.8% | $9.54B | $3.12 | 15.1% | 20.6% |
| 2020 | -$8.99B | -361.6% | $4.49B | $-3.98 | -21.2% | 10.6% |
| 2019 | $3.44B | -30.1% | $6.44B | $2.01 | 13.2% | 24.6% |
| 2018 | $4.92B | +388.6% | $6.39B | $3.03 | 21.8% | 28.3% |
| 2017 | $1.01B | -77.4% | $5.24B | $0.61 | 4.8% | 25.2% |
| 2016 | $4.46B | +184.8% | $5.18B | $2.65 | 22.9% | 26.7% |
Full BMY Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See BMY's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BMY Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BMY vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBMY — Frequently Asked Questions
Quick answers to the most common questions about buying BMY stock.
Is BMY growing earnings?
BMY EPS is $3.56, with earnings growth accelerating to +178.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $7.3B.
What are BMY's profit margins?
Bristol-Myers Squibb Company net margin is +14.6%, with operating margin at +26.3%. Margins sit within typical range for the sector.
How consistent are BMY's earnings?
BMY earnings data spans 1989-2025. The accelerating earnings trend is +178.2% YoY. Historical data enables comparison across business cycles.